Arch Venture Partners X, LLC

Number of records: 11
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
20-Feb-24 5:37 PM
View: 
Prime Medicine, Inc. (PRME) 15-Feb-24Private Purchase 3,200,000$6.25$20,000,000.0026%
12.26M to 15.46M
12-Dec-23 7:52 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 08-Dec-23Acquisition (other)
Duplicate
1,879,650----6%
30.05M to 31.93M
20-Sep-23 6:15 AM
View: 
Neumora Therapeutics, Inc. (NMRA) 19-Sep-23Conversion 17,424,700----164%
10.62M to 28.05M
20-Sep-23 6:16 AM
View: 
Neumora Therapeutics, Inc. (NMRA) 19-Sep-23Conversion
Duplicate
17,424,700----164%
10.62M to 28.05M
20-Sep-23 6:15 AM
View: 
Neumora Therapeutics, Inc. (NMRA) 19-Sep-23Purchase 1,500,000$17.00$25,500,000.005%
28.05M to 29.55M
20-Sep-23 6:16 AM
View: 
Neumora Therapeutics, Inc. (NMRA) 19-Sep-23Purchase
Duplicate
1,500,000$17.00$25,500,000.005%
28.05M to 29.55M
26-Oct-22 8:01 PM
View: 
Prime Medicine, Inc. (PRME) 24-Oct-22Conversion 11,456,600----100%
11.46M to 22.91M
26-Oct-22 8:01 PM
View: 
Prime Medicine, Inc. (PRME) 24-Oct-22Market Purchase
Duplicate
800,000$17.00$13,600,000.003%
22.91M to 23.71M
20-Jul-21 8:53 PM
View: 
Erasca, Inc. (ERAS) 20-Jul-21Conversion 11,055,600----100%
0 to 11.06M
23-Jun-21 4:29 PM
View: 
Verve Therapeutics, Inc. (VERV) 21-Jun-21Conversion 2,508,810----100%
0 to 2.51M
26-Feb-19 10:00 PM
View: 
Sienna Biopharmaceuticals, ... (SNNA) 22-Feb-19Market Purchase
Duplicate
2,165,800$2.50$5,414,500.00296%
732.49K to 2.9M
1%